Position in MNKD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,475,213
+$4,380,322 QoQ
Shares Held
2,693,712
-7.0% QoQ
Ownership
0.838%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 254 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. MNKD ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in MNKD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,475,213 | 2,693,712 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,094,891 | 2,895,874 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,738,443 | 1,188,438 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,794,972 | 2,010,237 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,447,225 | 2,525,996 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,893,858 | 3,358,620 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,409,874 | 3,174,164 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,116,744 | 3,039,228 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,744,422 | 2,824,602 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,876,353 | 2,400,961 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,691,425 | 1,014,128 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,508,437 | 2,302,285 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,042,038 | 2,221,631 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,592,965 | 3,071,455 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,835,899 | 1,486,888 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $331,791 | 107,376 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,561,740 | 934,840 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $310,497 | 56,972 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,616,305 | 1,942,935 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,147,300 | 1,325,016 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,807,326 | 1,493,259 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,232,233 | 1,275,562 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||